Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

NCT07535710 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma Refractory
Cutaneous T-Cell Lymphoma, Relapsed
Sezary Syndrome
Cutaneous T Cell Lymphoma (CTCL)

Interventions

DRUG: Aclarubicin
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Prednisone

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]